H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 188 Citations 180,431 723 World Ranking 93 National Ranking 67

Research.com Recognitions

Awards & Achievements

2017 - Distinguished Fellowship Award, American College of Cardiology (ACC)

2015 - Distinguished Scientist Award, American Heart Association

2013 - James B. Herrick Award for Outstanding Achievement in Clinical Cardiology, American Heart Association

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Myocardial infarction
  • Heart failure

The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Heart failure and Surgery. His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Endocrinology. His Cardiology research incorporates themes from ACE inhibitor and Blood pressure.

Marc A. Pfeffer combines subjects such as Captopril and Pravastatin with his study of Myocardial infarction. His Heart failure research is multidisciplinary, incorporating perspectives in Candesartan, Survival analysis, Proportional hazards model and Coronary artery disease. His Surgery study combines topics from a wide range of disciplines, such as Diabetes mellitus, Stroke, Clinical trial and Risk factor.

His most cited work include:

  • The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels (6753 citations)
  • EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION. RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL (5142 citations)
  • Intensive versus moderate lipid lowering with statins after acute coronary syndromes. (3936 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Cardiology, Heart failure, Myocardial infarction and Ejection fraction are his primary areas of study. His Internal medicine study combines topics in areas such as Endocrinology and Surgery. His Cardiology study frequently draws parallels with other fields, such as Valsartan.

As a part of the same scientific family, Marc A. Pfeffer mostly works in the field of Heart failure, focusing on Placebo and, on occasion, Randomized controlled trial. His studies deal with areas such as Stroke, Captopril and Risk factor as well as Myocardial infarction. He interconnects Diastole and Atrial fibrillation in the investigation of issues within Ejection fraction.

He most often published in these fields:

  • Internal medicine (89.21%)
  • Cardiology (71.01%)
  • Heart failure (49.44%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (89.21%)
  • Cardiology (71.01%)
  • Heart failure (49.44%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Cardiology, Heart failure, Ejection fraction and Heart failure with preserved ejection fraction. His work on Myocardial infarction, Hazard ratio and Spironolactone is typically connected to In patient as part of general Internal medicine study, connecting several disciplines of science. His Myocardial infarction research incorporates elements of Stroke, Framingham Risk Score and Sudden cardiac death.

His work carried out in the field of Cardiology brings together such families of science as Candesartan, Proportional hazards model and Renal function. His Heart failure study incorporates themes from Kidney disease, Valsartan and Atrial fibrillation. His research integrates issues of Interquartile range, Incidence, Cause of death, Clinical endpoint and Troponin T in his study of Ejection fraction.

Between 2015 and 2021, his most popular works were:

  • Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. (1007 citations)
  • Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction (419 citations)
  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (219 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Heart failure
  • Myocardial infarction

Marc A. Pfeffer mainly investigates Internal medicine, Heart failure, Cardiology, Heart failure with preserved ejection fraction and Ejection fraction. Marc A. Pfeffer works mostly in the field of Internal medicine, limiting it down to topics relating to Diabetes mellitus and, in certain cases, Acute coronary syndrome. His research in Heart failure intersects with topics in Endocrinology and Baseline characteristics.

His studies in Cardiology integrate themes in fields like Candesartan, Aldosterone and Confidence interval. His Ejection fraction research also works with subjects such as

  • Diastole which connect with Speckle tracking echocardiography,
  • Angiotensin receptor which connect with Heart disease. His research investigates the connection between Myocardial infarction and topics such as Type 2 diabetes that intersect with issues in MEDLINE.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

F. M. Sacks;M. A. Pfeffer;L. A. Moye;J. L. Rouleau.
The New England Journal of Medicine (1996)

9649 Citations

EFFECT OF CAPTOPRIL ON MORTALITY AND MORBIDITY IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION. RESULTS OF THE SURVIVAL AND VENTRICULAR ENLARGEMENT TRIAL

Marc A. Pfeffer;Eugene Braunwald;Lemuel A. Moyé;Lofty Basta.
The New England Journal of Medicine (1992)

7053 Citations

Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

Christopher P. Cannon;Eugene Braunwald;Carolyn H. McCabe;Daniel J. Rader.
The New England Journal of Medicine (2004)

5959 Citations

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Mark J. Sarnak;Andrew S. Levey;Anton C. Schoolwerth;Josef Coresh.
Circulation (2003)

5472 Citations

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.

M A Pfeffer;E Braunwald.
Circulation (1990)

4002 Citations

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

John Jv McMurray;Jan Östergren;Karl Swedberg;Christopher B Granger.
The Lancet (2003)

3520 Citations

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf;Marc A Pfeffer;Karl Swedberg;Christopher B Granger.
The Lancet (2003)

3170 Citations

Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau.
The New England Journal of Medicine (2003)

3054 Citations

Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation

Stuart J. Connolly;Janice Pogue;Robert G. Hart;Stefan H. Hohnloser.
The New England Journal of Medicine (2009)

3027 Citations

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update Endorsed by the National Heart, Lung, and Blood Institute

Sidney C. Smith;Jerilyn Allen;Steven N. Blair;Robert O. Bonow.
Journal of the American College of Cardiology (2006)

2980 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Marc A. Pfeffer

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 410

Gregory Y.H. Lip

Gregory Y.H. Lip

University of Liverpool

Publications: 343

Scott D. Solomon

Scott D. Solomon

Brigham and Women's Hospital

Publications: 306

John G.F. Cleland

John G.F. Cleland

National Institutes of Health

Publications: 280

Gregg C. Fonarow

Gregg C. Fonarow

University of California, Los Angeles

Publications: 276

Christopher P. Cannon

Christopher P. Cannon

Brigham and Women's Hospital

Publications: 242

Paul M. Ridker

Paul M. Ridker

Harvard Medical School

Publications: 232

Faiez Zannad

Faiez Zannad

University of Lorraine

Publications: 226

Dirk J. van Veldhuisen

Dirk J. van Veldhuisen

University Medical Center Groningen

Publications: 225

Javed Butler

Javed Butler

University of Mississippi

Publications: 218

Marco Metra

Marco Metra

University of Brescia

Publications: 212

Adriaan A. Voors

Adriaan A. Voors

University Medical Center Groningen

Publications: 209

Lars Køber

Lars Køber

Copenhagen University Hospital

Publications: 203

Aldo P. Maggioni

Aldo P. Maggioni

Heart Care Foundation, ANMCO Research Center, Florence

Publications: 201

Mihai Gheorghiade

Mihai Gheorghiade

Northwestern University

Publications: 191

Something went wrong. Please try again later.